Shawn Guertin

Shawn Guertin

DirectoratCVS HEALTH· In proxies 2021–2025

Pay in FY2023-15% from the year before

Shawn Guertin was paid $12.5M in FY2023 (Dec), down 15%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each CVS HEALTH proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Evolent HealthPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. CVS HEALTHPublic company · 5 yr
    • Former Executive Vice President, Chief Financial Officer and President of Health Services2021 – Present · 5 yrNo stock prices for these years
  3. DaVita Inc.Public company · 1 yr
    • Director2020 – 2021 · 1 yrNo stock prices for these years
  4. TriNet Group, Inc.Public company · 1 yr
    • Director2020 – 2021 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Evolent HealthDirector · 0 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?